A class of drugs used to treat benign prostatic hyperplasia may help reduce a broad range of symptoms of Parkinson’s disease, international researchers say.

The Chinese-led research focused on the drug terazosin, which is not registered in Australia, but the authors say the effects appear similar with closely related drugs doxazosin and alfuzosin, which are on the Australian Register of Therapeutic Goods.